F
0.344
0.08 (32.27%)
| Penutupan Terdahulu | 0.260 |
| Buka | 0.270 |
| Jumlah Dagangan | 5,908,431 |
| Purata Dagangan (3B) | 1,917,357 |
| Modal Pasaran | 22,876,132 |
| Harga / Buku (P/B) | 138.36 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 14 Aug 2025 |
| EPS Cair (TTM) | -0.210 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 302.81% |
| Nisbah Semasa (MRQ) | 1.14 |
| Aliran Tunai Operasi (OCF TTM) | -12.90 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -17.74 M |
| Pulangan Atas Aset (ROA TTM) | -81.15% |
| Pulangan Atas Ekuiti (ROE TTM) | -559.73% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | FibroBiologics, Inc. | Bercampur | Menurun |
AISkor Stockmoo
2.5
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 2.50 |
|
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 21.42% |
| % Dimiliki oleh Institusi | 16.75% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Landscape Capital Management, L.L.C. | 30 Sep 2025 | 350,000 |
| Gts Securities Llc | 30 Sep 2025 | 308,661 |
| Cascade Financial Partners, Llc | 30 Sep 2025 | 298,081 |
| Cerity Partners Llc | 30 Sep 2025 | 125,919 |
| Optivise Advisory Services Llc | 30 Sep 2025 | 110,100 |
| Requisite Capital Management, Llc | 30 Sep 2025 | 109,713 |
| &Partners | 30 Sep 2025 | 100,000 |
| American Institute For Advanced Investment Management, Llp | 30 Sep 2025 | 88,206 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 15.00 (D. Boral Capital, 4,261.73%) | Beli |
| Median | 10.00 (2,807.82%) | |
| Rendah | 5.00 (HC Wainwright & Co., 1,353.91%) | Beli |
| Purata | 10.00 (2,807.82%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 0.250 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| D. Boral Capital | 06 Jan 2026 | 15.00 (4,261.73%) | Beli | 0.260 |
| 20 Nov 2025 | 15.00 (4,261.73%) | Beli | 0.325 | |
| HC Wainwright & Co. | 02 Jan 2026 | 5.00 (1,353.91%) | Beli | 0.240 |
| 05 Nov 2025 | 5.00 (1,353.91%) | Beli | 0.370 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |